Difficult-to-control asthma. Contributing factors and outcome of a systematic management protocol - PubMed (original) (raw)
Difficult-to-control asthma. Contributing factors and outcome of a systematic management protocol
R S Irwin et al. Chest. 1993 Jun.
Abstract
To our knowledge, there are no published results of protocols for managing difficult to control asthma (DTCA) or of the spectrum and frequencies of reasons why asthma can be difficult to control (DTC). To assess the usefulness of a systematic management protocol and determine the reason(s) why asthmatics are DTC, we developed a protocol that systematically considered multiple factors that may make asthma worse and prospectively evaluated the outcomes of therapeutic interventions for these factors and of inhaled corticosteroids (ICS) and azathioprine. We studied 42 consecutive and unselected DTCAs (19 men and 23 women) whose age was 48 +/- 15.9 years. They had a diagnosis of asthma for 15.1 +/- 15.8 years, were DTC for 4.8 +/- 7.8 years, and were followed up by us in the study for a total of 3.5 +/- 1.9 years. Initially, the dose of prednisone was 30.2 +/- 22 mg/d. Following utilization of the protocol, 74 percent were no longer DTC. It took 1.8 +/- 1.7 years for them to no longer be DTC; they remained so for 1.8 +/- 1.5 years. In these patients, 2.7 +/- 1.2 factors appeared to be responsible for the DTC state; 80 percent had > or = 2. Improvement was more likely if gastroesophageal reflux (GER) was a factor (p = 0.014); it correlated with the addition of ICS (p = 0.04) and treatment for GER (p = 0.02). Failure to reverse DTCA correlated with the suspicion (p = 0.004) and admission of nonadherence (p = 0.04). In 14 patients given azathioprine, prednisone dose decreased from 45 +/- 25.3 to 13.3 +/- 21.6 mg/d (p = 0.003); 6 of 14 achieved no longer DTC status; and substantial morbidity occurred. The reason(s) for DTCA could be determined in most instances by utilizing a systematic protocol; multiple factors were responsible in the majority of cases; treatment for GER and ICS were the two most helpful interventions; nonadherence was the most likely reason suspected for maintaining DTCA; and azathioprine acted as a corticosteroid-sparing agent that should not be prescribed routinely.
Similar articles
- Asthmatics with gastroesophageal reflux: long term results of a randomized trial of medical and surgical antireflux therapies.
Sontag SJ, O'Connell S, Khandelwal S, Greenlee H, Schnell T, Nemchausky B, Chejfec G, Miller T, Seidel J, Sonnenberg A. Sontag SJ, et al. Am J Gastroenterol. 2003 May;98(5):987-99. doi: 10.1111/j.1572-0241.2003.07503.x. Am J Gastroenterol. 2003. PMID: 12809818 Clinical Trial. - Role of gastroesophageal reflux in older children with persistent asthma.
Khoshoo V, Le T, Haydel RM Jr, Landry L, Nelson C. Khoshoo V, et al. Chest. 2003 Apr;123(4):1008-13. doi: 10.1378/chest.123.4.1008. Chest. 2003. PMID: 12684287 - Gastroesophageal reflux disease and asthma.
Sontag SJ. Sontag SJ. J Clin Gastroenterol. 2000 Apr;30(3 Suppl):S9-30. J Clin Gastroenterol. 2000. PMID: 10777168 Review. - Association of asthma with gastroesophageal reflux disease in children.
Ay M, Sivasli E, Bayraktaroglu Z, Ceylan H, Coskun Y. Ay M, et al. J Chin Med Assoc. 2004 Feb;67(2):63-6. J Chin Med Assoc. 2004. PMID: 15146900 - Asthma and gastroesophageal reflux in children.
Wasowska-Królikowska K, Toporowska-Kowalska E, Krogulska A. Wasowska-Królikowska K, et al. Med Sci Monit. 2002 Mar;8(3):RA64-71. Med Sci Monit. 2002. PMID: 11887043 Review.
Cited by
- Multidisciplinary care in chronic airway diseases: the Newcastle model.
McDonald VM, Harrington J, Clark VL, Gibson PG. McDonald VM, et al. ERJ Open Res. 2022 Aug 15;8(3):00215-2022. doi: 10.1183/23120541.00215-2022. eCollection 2022 Jul. ERJ Open Res. 2022. PMID: 35983538 Free PMC article. - Prevalence and Spectrum of Gastro Esophageal Reflux Disease in Bronchial Asthma.
Rameschandra S, Acharya V, Kunal, Vishwanath T, Ramkrishna A, Acharya P. Rameschandra S, et al. J Clin Diagn Res. 2015 Oct;9(10):OC11-4. doi: 10.7860/JCDR/2015/14760.6645. Epub 2015 Oct 1. J Clin Diagn Res. 2015. PMID: 26557556 Free PMC article. - Why do some asthma patients respond poorly to glucocorticoid therapy?
Henderson I, Caiazzo E, McSharry C, Guzik TJ, Maffia P. Henderson I, et al. Pharmacol Res. 2020 Oct;160:105189. doi: 10.1016/j.phrs.2020.105189. Epub 2020 Sep 8. Pharmacol Res. 2020. PMID: 32911071 Free PMC article. Review. - Predictors of therapy resistant asthma: outcome of a systematic evaluation protocol.
Heaney LG, Conway E, Kelly C, Johnston BT, English C, Stevenson M, Gamble J. Heaney LG, et al. Thorax. 2003 Jul;58(7):561-6. doi: 10.1136/thorax.58.7.561. Thorax. 2003. PMID: 12832665 Free PMC article. - Improving patient adherence with asthma self-management practices: what works?
Eakin MN, Rand CS. Eakin MN, et al. Ann Allergy Asthma Immunol. 2012 Aug;109(2):90-2. doi: 10.1016/j.anai.2012.06.009. Ann Allergy Asthma Immunol. 2012. PMID: 22840247 Free PMC article. No abstract available.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical